By leveraging the urease-catalyzed decomposition of urea in urine, a persistent driving force was provided to realize the targeted delivery of anti-FGFR3 antibody in bladder cancer cells' 3D spheroids. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.